MECP2 and Rett syndrome: Thus, in RTT, a dysregulated inflammatory response driven by the MeCp2-NF-κB axis and an unrestrained glutamate production (i.e., high glutaminase expression) could contribute to and exacerbate the disease (O’Driscoll et al., 2013) (Figure 5).